LURASIDONE HYDROCHLORIDE | A212244 | ALKEM LABORATORIES LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
SUMITOMO DAINIPPON PHARMA CO., LTD. et al v. ALKEM LABORATORIES LIMITED 2 patentsANDA 212244lurasidone hydrochloride | D.N.J. | 2018-10-09 | Terminated 2019-01-02 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.4889
per ea
Lowest NADAC/Unit
$0.1348
per ea
Brand NDCs
0
Generic NDCs
14
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00904735904LURASIDONE HCL 120 MG TABLET | $0.4889 | EA | Generic | — | 2026-06-17 |
| 67877064230LURASIDONE HCL 120 MG TABLET | $0.4889 | EA | Generic | — | 2026-06-17 |
| 00904735861LURASIDONE HCL 80 MG TABLET | $0.3366 | EA | Generic | — | 2026-06-17 |
| 60687078021LURASIDONE HCL 80 MG TABLET | $0.3366 | EA | Generic | — | 2026-06-17 |
| 67877064130LURASIDONE HCL 80 MG TABLET | $0.3366 | EA | Generic | — | 2026-06-17 |
| 00904735761LURASIDONE HCL 60 MG TABLET | $0.3018 | EA | Generic | — | 2026-06-17 |
Showing 6 of 14 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.